( University of Cincinnati Academic Health Center ) The University of Cincinnati will lead a $5.2 million national trial studying removal of both corticosteroids and common immunosuppression treatments from the post-transplant drug regimen for kidney transplant patients. The Belatacept Early Steroid withdrawal Trial seeks to determine if a belatacept-based regimen for post-transplant patients ...
